类风湿关节炎的生物制剂治疗  

Biologic agents for rheumatoid arthritis treatment

作　　者：陈龙[1] 袁国华[1] 

机构地区：[1]川北医学院风湿免疫研究所,四川南充637000

出　　处：《实用医院临床杂志》2011年第2期10-13,共4页Practical Journal of Clinical Medicine

摘　　要：类风湿关节炎(rheum atoid arthritis,RA)是一种常见的致残性疾病,严重影响患者的生活质量。传统的RA药物治疗主要包括非甾体抗炎药、糖皮质激素以及慢作用药物,然而这些药物常常不能满意控制那些难治性RA患者的病情,最终导致关节进行性破坏。近年,由于多种生物制剂的出现,为治疗难治性RA带来了希望,这些生物制剂在控制风湿病情和改善生活质量方面发挥了重要作用。Rheumatoid arthritis is a common disabling diease,seriously affecting the patients＇ quality of life.Traditional drugs treatment for rheumatoid arthritis include nonsteroid anti-inflammatory drugs,corticosteroids,and disease modifying antirheumatic drugs,however,these drugs are often not satisfied to control the condition of refractory rheumatoid arthritis,and resulting in severe joint damage.Recently,the emergence of multiple biological agents brought hope to the treatment of refractory rheumatoid arthritis patients.These agents play an important role in the control of rheumatic conditions and the improvement of quality of life in RA patients.

关 键 词：类风湿关节炎 生物制剂 治疗 

分 类 号：R593.22[医药卫生—内科学]